A Randomized, Active-Controlled, Double-Blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliparidone in the Treatment of Schizophrenia

This study has been completed.

Study NCT00350467 Information provided by Xian-Janssen Pharmaceutical Ltd.

First Received: July 7, 2006 Last Updated: September 19, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given